Process for the preparation of optically active chiral amines

US9551018B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9551018-B2
Application numberUS-201514740646-A
CountryUS
Kind codeB2
Filing dateJun 16, 2015
Priority dateFeb 13, 2006
Publication dateJan 24, 2017
Grant dateJan 24, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to the production of optically pure secondary amines, which can be used as intermediate products in a synthesis of for instance pharmaceutical products.

First claim

Opening claim text (preview).

What is claimed is: 1. A process for the preparation of a compound selected from a group consisting of 3-aminopyrrolidone derivatives, chephalosporine, derivatives of cephalosporine, heterocyclic boronic acids, L-dihydroxphenylalanine (L-Dopa), α-methyldopa, D-phenylglycine, β-hydroxyphenylglycine, phosphinothricine, pyrimido derivatives and pyrrolidone derivatives, the process comprising: a) providing an amino acceptor and an amino donor, b) reacting the amino acceptor and the amino donor with a transaminase, c) obtaining a desired optically active chiral amine and a ketone by-product, and d) converting the optically active chiral amine to the compound, and wherein the amino acceptor is selected from a group consisting of phenylpyruvic acid, a salt thereof, pyruvic acid, a salt thereof, 2-ketoglutarate, 3-oxobutyrate, 2-butanone, 3-oxopyrrolidine, 3-pyridylmethylketone, 3-oxobutyric acid ethyl ester, 3-oxopentanoic acid methyl ester, N-1-boc-3-oxopiperidinone, N-1-boc-3-oxopyrrolidine, 3-oxo-piperidine, alkyl-3-oxo-butonoates, methoxy-acetone and 1-oxotetralone. 2. The process according to claim 1 , wherein the transaminase is a (R)- or (S)-selective transaminase. 3. The process according to claim 1 , wherein the amino donor is selected from the group consisting of amines or amino acids, in particular from β-alanine, alanine, α-methylbenzylamine (α-MBA), glutamate, phenylalanine and γ-aminobutyrate, glycin, 3-aminobutyrate, isopropylamine, 2-aminobutane and a salt, for instance a chloride, of any one thereof. 4. The process according to claim 1 , wherein the obtained amines are amines, in particular mono- or bicyclic amines, in particular amines of 5 to 6-membered cyclic or S-, O-, or N-substituted heterocyclic hydrocarbons or aromatic amines, in particular alkyl- or alkoxy-substituted aromatic amines. 5. The process according to claim 1 , wherein the obtained amines are selected from the group consisting of phenylalanine, alanine, 3-am inopiperidine, alkyl-3-amino-butanoates, 3-aminopyrrolidine (3-AP), 3-pyridyl-1-ethylamine (3-PEA), N-1-boc-3-aminopyrrolidine (B3AP), 3-aminobutyric acid ethyl ester (3-ABEE), 3-aminopentanoic acid methyl ester (3-APME), α-methylbenzylamine (α-MBA), 1-aminotetraline, α-methyl-4-(3-pyridyl)-butanamine, glutamate, β-aminobutyrate, sec-butylamine, methoxyisopropylamine, derivatives of 3-aminopyrrolidine, 1-N-boc-3-aminopiperidin, cephalosporine and derivatives of cephalosporine. 6. The process according to claim 1 , wherein the transaminase is from Vibrio fluvialis, Alcaligenes denitrificans, Klebsiella pneumoniae or Bacillus thuringiensis. 7. The process according to claim 1 , wherein the ketone by-product obtained in step c is pyruvate. 8. The process according to claim 1 , wherein the ketone by-product obtained in step c) is in a further process step e) removed from by reaction with at least one enzyme. 9. The process according to claim 8 , wherein the enzyme used in step e) is a decarboxylase. 10. The process according to claim 8 , wherein the at least one enzyme used in step e) is a synthase. 11. The process according to claim 8 , wherein the enzyme used in step e) is a dehydrogenase. 12. The process according to claim 8 , wherein the enzyme is a pyruvate decarboxylase (PDC). 13. The process according to claim 8 , wherein the enzyme is a lactate dehydrogenase (LDH). 14. The process according to claim 8 , wherein the enzyme is an acetolactate synthase. 15. The process according to claim 12 , wherein acetaldehyde formed by the action of the PDC is removed. 16. The process according to claim 15 , where acetaldehyde is removed by reaction with at least one enzyme. 17. The process according to claim 16 , wherein the enzyme is an alcohol dehydrogenase. 18. The process according to claim 15 , wherein the acetaldehyde is removed by feeding gaseous nitrogen into the reaction mixture. 19. The process according to claim 15 , wherein the acetaldehyde is removed by applying a reduced pressure to the reaction mixture. 20. The process according to claim 15 , wherein the acetaldehyde is removed by chemical methods. 21. The process according to claim 1 , further comprising removing the optically active chiral amine obtained in step c). 22. The process according to claim 1 , wherein the process is carried out in a reaction mixture having a pH from 5.0 to 9.5, preferably 6.0 to 7.0, preferably 6.0 to 6.9. 23. The process according to claim 1 , wherein the process is carried out for a reaction time of 40 to 70 minutes. 24. A process for the preparation of a compound selected from 3-aminopyrrolidone derivatives, the process comprising: a) providing an amino acceptor and an amino donor, b) reacting the amino acceptor and the amino donor with a transaminase, c) obtaining a desired optically active chiral amine and a ketone by-product, and d) converting the optically active chiral amine to the compound, and wherein the amino acceptor is N-1-boc-3-oxopyrrolidine. 25. The process according to claim 1 , wherein the amino donor is alanine. 26. The process according to claim 12 , wherein the acetaldehyde formed by the reaction of the PDC is removed by feeding gaseous nitrogen (N 2 ) into the reaction mixture. 27. The process according to claim 12 , wherein the reaction is carried out in the presence of at least one pyruvate decarboxylase and at least one alcohol dehydrogenase. 28. The process according to claim 12 , wherein the reaction is carried out in the presence of at least one pyruvate decarboxylase, at least one alcohol dehydrogenase and additionally in the presence of gaseous nitrogen (N 2 ).

Assignees

Inventors

Classifications

  • Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)} · CPC title

  • Beta-alanine-pyruvate transaminase (2.6.1.18) · CPC title

  • C12N9/1096Primary

    transferring nitrogenous groups (2.6) · CPC title

  • Amines; Imines · CPC title

  • Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9551018B2 cover?
The present invention relates to the production of optically pure secondary amines, which can be used as intermediate products in a synthesis of for instance pharmaceutical products.
Who is the assignee on this patent?
Lonza Ag
What technology area does this patent fall under?
Primary CPC classification C12N9/1096. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).